What is included in patient education about diffuse large cell lymphoma?

Updated: Jun 12, 2019
  • Author: Shipra Gandhi, MBBS; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Patients with diffuse large B-cell lymphoma should receive information about the following:

  • Febrile neutropenia

  • Postchemotherapy thrombocytopenia and the tendency to bleed with minimal trauma

  • Chemotherapy-associated alopecia

  • Avoidance of pregnancy in reproductive-aged women

  • Chemotherapy-induced nausea and vomiting

  • Chemotherapy-associated menstrual dysregulation (females) and the possibility of sexual dysfunction

  • Other sequelae of chemotherapeutic agents - Including secondary leukemias, myelodysplastic syndrome, anaphylactic reactions, and potentially fatal infections

  • Fatigue

  • Sperm banking and risk of sterility for males

Clearly explain transfusions (red blood cells and platelets) and associated complications. In addition, discuss the possibility of (1) long-term complications of higher doses of chemoradiotherapy and (2) mortality rates as high as 3-5% from the conditioning regimen in patients who require HDC and ASCT.

For patient education information, see Leukemia and Lymphoma and Non-Hodgkin Lymphoma.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!